Tiaprofenic acid
| Systematic (IUPAC) name | |
|---|---|
| (RS)-2-(5-benzoyl-2-thienyl)propanoic acid | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | C |
| Legal status | POM |
| Routes | oral |
| Pharmacokinetic data | |
| Bioavailability | 90% |
| Metabolism | 10% hepatic |
| Half-life | 1.5-2.5h |
| Excretion | 50-80% urine |
| Identifiers | |
| CAS number | 33005-95-7 |
| ATC code | M01AE11 |
| PubChem | CID 5468 |
| DrugBank | DB01600 |
| ChemSpider | 5269 |
| UNII | 1LS1T6R34C |
| KEGG | D01325 |
| ChEBI | CHEBI:32221 |
| ChEMBL | CHEMBL365795 |
| Synonyms | 5-Benzoyl-α-methyl-2-thiopheneacetic acid |
| Chemical data | |
| Formula | C14H12O3S |
| Mol. mass | 260.309 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Tiaprofenic acid is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain. The typical adult dose is 300 mg twice daily. It is not recommended in children.
It is sparingly metabolised in the liver to two inactive metabolites. Most of the drug is eliminated unchanged in the urine. Renal disease impairs excretion, and it should be used with caution in renal disease.
Long-term use of tiaprofenic acid is associated with severe cystitis, roughly 100 times more commonly than other NSAIDs.[1] It is contraindicated in patients with cystitis and urinary tract infections.
It is marketed under the trade names Surgam, Surgamyl and Tiaprofen, and in generic formulations. A sustained-release preparation is available.
[edit] References
- ^ Crawford MLA, Waller PC, Wood SM (1997). "Severe cystitis associated with tiaprofenic acid". British Journal of Urology 79 (4): 578–584. doi:10.1046/j.1464-410X.1997.00094.x. PMID 9126086.
[edit] External links
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |